Revenue
2022
2023
2024
2025
Anbio Biotechnology (NNNN)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $8.6M | $8.2M | $6.7M | $23.5M |
| Gross profit | $7.5M | $5.9M | $3.4M | $12.6M |
| Research & development | $201,305 | $454,227 | $134,700 | $200,000 |
| Operating expenses | $1.8M | $3.9M | $1.4M | $2.4M |
| Operating income | $5.8M | $2.0M | $2.0M | $10.2M |
| Net income | $6.4M | $2.4M | $2.3M | $10.0M |
| Basic EPSper diluted share | $0.15 | $0.06 | $0.11 | $100,112.00 |
| Diluted EPSper diluted share | $0.15 | $0.06 | $0.11 | $100,112.00 |